Diagnostics criteria for arterial hypertension in conns disease
Reading File
search_medical_text
Conn's disease primary hyperaldosteronism arterial hypertension diagnostic criteria
search_medical_text
primary aldosteronism screening confirmatory tests hypertension diagnosis
GradeResponse
GradeResponse
search_medical_text
aldosterone renin ratio ARR cutoff primary aldosteronism screening hypertension
search_medical_text
primary aldosteronism confirmatory testing salt loading fludrocortisone suppression test
Diagnostic Criteria for Arterial Hypertension in Conn's Disease (Primary Hyperaldosteronism)
Conn's disease refers to primary hyperaldosteronism (PA) — first described in 1957 — characterized by hypertension and inappropriately elevated plasma aldosterone independent of the renin-angiotensin system. Below is a structured diagnostic approach.
1. When to Suspect / Who to Screen
Screening for PA should be performed in hypertensive patients with any of the following:
| Indication | Details |
|---|---|
| Resistant hypertension | BP uncontrolled on ≥3 drugs including a diuretic |
| Spontaneous or diuretic-induced hypokalemia | K⁺ < 3.5 mmol/L |
| Hypertension + adrenal incidentaloma | Regardless of K⁺ level |
| Hypertension with onset < 40 years | Especially with family history |
| Hypertension + obstructive sleep apnea | |
| First-degree relative with PA | |
| Hypertensive patients with AF or stroke at young age |
BP thresholds that raise suspicion:
- Stage 2 hypertension (≥160/100 mmHg) or Stage 3 (≥180/110 mmHg)
- Drug-resistant hypertension (≥140/90 mmHg despite ≥3 agents)
2. Screening Test — Aldosterone-to-Renin Ratio (ARR)
The ARR is the primary screening tool (Endocrine Society Guidelines).
Conditions before testing:
- Correct hypokalemia
- Ensure adequate sodium intake
- Withdraw interfering medications for ≥4 weeks: spironolactone, eplerenone, amiloride, K⁺-wasting diuretics, licorice
- Withdraw for ≥2 weeks: ACE inhibitors, ARBs, dihydropyridine CCBs, β-blockers (which suppress renin and can falsely elevate ARR)
- Alpha-blockers (e.g., doxazosin) and verapamil are preferred antihypertensives during workup
ARR cutoff values (commonly used):
| Units | ARR Positive Threshold |
|---|---|
| ng/dL ÷ ng/mL/h (PAC/PRA) | ≥30 (with PAC ≥ 15 ng/dL) |
| pmol/L ÷ mIU/L | ≥70–100 (laboratory-dependent) |
A positive ARR alone is not diagnostic — confirmatory testing is required.
3. Confirmatory Tests (Positive Screening → Confirm PA)
At least one confirmatory test should be performed (unless spontaneous hypokalemia + undetectable renin + PAC > 20 ng/dL, which is sufficient):
| Test | Protocol | Positive Criterion |
|---|---|---|
| Oral sodium loading | 3 days high sodium diet (>200 mmol/day) + check 24h urine aldosterone | Urinary aldosterone > 12–14 µg/24h |
| Saline infusion test (SIT) | 2L 0.9% NaCl IV over 4h; measure PAC at 0 and 4h | PAC > 10 ng/dL post-infusion = positive; <5 ng/dL = negative |
| Fludrocortisone suppression test (FST) | Fludrocortisone 0.1 mg q6h × 4 days + NaCl; measure PAC on day 4 | PAC > 6 ng/dL (upright, 10 AM) with renin suppressed |
| Captopril challenge test | Captopril 25–50 mg PO; measure PAC at 0, 1–2h | PAC > 11 ng/dL or failure to suppress by ≥30% |
The saline infusion test is the most widely used in clinical practice.
4. Subtype Differentiation (After PA Confirmed)
| Method | Purpose |
|---|---|
| Adrenal CT scan | Identify adenoma vs. bilateral hyperplasia; CT alone insufficient for subtype |
| Adrenal vein sampling (AVS) | Gold standard — distinguishes unilateral adenoma (Conn's classic) from bilateral hyperplasia; lateralization ratio ≥2:1 (post-ACTH: ≥4:1) indicates unilateral disease |
CT alone misclassifies up to 37% of cases — AVS is required before surgical decision-making.
5. Biochemical Diagnosis Summary
A definitive diagnosis of PA requires:
- Hypertension (often resistant or severe)
- Elevated plasma aldosterone (PAC > 10–15 ng/dL)
- Suppressed plasma renin (PRA < 1 ng/mL/h or direct renin < 5–10 mIU/L)
- Positive ARR (≥30 using ng/dL / ng/mL/h)
- Confirmed by at least one suppression test
6. Associated Features Supporting the Diagnosis
- Hypokalemia (present in ~40% of PA; its absence does NOT exclude PA)
- Metabolic alkalosis
- Polyuria / nocturia (from K⁺ depletion)
- Muscle weakness / cramps
- Elevated urinary potassium excretion (urine K⁺ > 30 mmol/day despite hypokalemia)
Sources: Bailey & Love's Short Practice of Surgery, 28th ed. (p. 912); Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment — Endocrine Society / GLGCA Guidelines (p. 18); supplemented with Endocrine Society Clinical Practice Guideline 2016 (Funder et al.).
This is a shared conversation. Sign in to Orris to start your own chat.